About Octapharma AG
Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality human proteins. The Company has grown to 2,500 employees in 27 countries since its founding in 1983. Octapharma owns five modern, state-of-the-art production facilities in Austria, France, Sweden, Mexico and Germany. Sales turnover in 2007 exceeded Euro 752 million. Octapharma continues to grow and invest heavily in the future. Profits are mainly channeled into R&D and further improvements and expansion of Production. In the highly demanding market of life-saving plasma products, Company success is only possible through reliable product quality and a proven safety record.
Octaplas(R) is a pharmaceutical quality human coagulation active plasma
for transfusion. Besides being solvent/detergent virus inactivated, the
product is standardized, which promotes a better planning and monitoring of
treatment. Furthermore, the removal of all residual blood cells and
neutralization of both allergens and antibodies against leukocytes render
this medicinal product virtually free from causing allergic reactions and
the risk for transfusion-related acute lung injuries ("TRALI"), being the
most common cause of death in transfusion medicine, has been abolished.
Octaplas(R) increases through these multiple fav
|SOURCE PROMETIC LIFE SCIENCES INC.|
Copyright©2008 PR Newswire.
All rights reserved